Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Crohn's Disease Drug, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Crohn's Disease Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Crohn's Disease Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Crohn's Disease Drug Market Size Growth Rate by Type
    • 1.4.2 Aminosalicylates
    • 1.4.3 Corticosteroids
    • 1.4.4 Immunomodulators
    • 1.4.5 Antibiotics
  • 1.5 Market by Application
    • 1.5.1 Global Crohn's Disease Drug Market Size Growth Rate by Application
    • 1.5.2 Achieving Remission (The Absence Of Symptoms)
    • 1.5.3 Maintaining Remission (Prevention Of Flare-Ups)
    • 1.5.4 Pediatric Crohn'S Disease
  • 1.6 Coronavirus Disease 2019 (Covid-19): Crohn's Disease Drug Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Crohn's Disease Drug Industry
      • 1.6.1.1 Crohn's Disease Drug Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Crohn's Disease Drug Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Crohn's Disease Drug Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Crohn's Disease Drug Market Size Estimates and Forecasts
    • 2.1.1 Global Crohn's Disease Drug Revenue 2015-2026
    • 2.1.2 Global Crohn's Disease Drug Sales 2015-2026
  • 2.2 Crohn's Disease Drug Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Crohn's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Crohn's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Crohn's Disease Drug Competitor Landscape by Players

  • 3.1 Crohn's Disease Drug Sales by Manufacturers
    • 3.1.1 Crohn's Disease Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Crohn's Disease Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Crohn's Disease Drug Revenue by Manufacturers
    • 3.2.1 Crohn's Disease Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Crohn's Disease Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Crohn's Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Crohn's Disease Drug Revenue in 2019
    • 3.2.5 Global Crohn's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Crohn's Disease Drug Price by Manufacturers
  • 3.4 Crohn's Disease Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Crohn's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Crohn's Disease Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Crohn's Disease Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Crohn's Disease Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Crohn's Disease Drug Sales by Type (2015-2020)
    • 4.1.2 Global Crohn's Disease Drug Revenue by Type (2015-2020)
    • 4.1.3 Crohn's Disease Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Crohn's Disease Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Crohn's Disease Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Crohn's Disease Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Crohn's Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Crohn's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Crohn's Disease Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Crohn's Disease Drug Sales by Application (2015-2020)
    • 5.1.2 Global Crohn's Disease Drug Revenue by Application (2015-2020)
    • 5.1.3 Crohn's Disease Drug Price by Application (2015-2020)
  • 5.2 Crohn's Disease Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Crohn's Disease Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Crohn's Disease Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Crohn's Disease Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Crohn's Disease Drug by Country
    • 6.1.1 North America Crohn's Disease Drug Sales by Country
    • 6.1.2 North America Crohn's Disease Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Crohn's Disease Drug Market Facts & Figures by Type
  • 6.3 North America Crohn's Disease Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Crohn's Disease Drug by Country
    • 7.1.1 Europe Crohn's Disease Drug Sales by Country
    • 7.1.2 Europe Crohn's Disease Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Crohn's Disease Drug Market Facts & Figures by Type
  • 7.3 Europe Crohn's Disease Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Crohn's Disease Drug by Region
    • 8.1.1 Asia Pacific Crohn's Disease Drug Sales by Region
    • 8.1.2 Asia Pacific Crohn's Disease Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Crohn's Disease Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Crohn's Disease Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Crohn's Disease Drug by Country
    • 9.1.1 Latin America Crohn's Disease Drug Sales by Country
    • 9.1.2 Latin America Crohn's Disease Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Crohn's Disease Drug Market Facts & Figures by Type
  • 9.3 Central & South America Crohn's Disease Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Crohn's Disease Drug by Country
    • 10.1.1 Middle East and Africa Crohn's Disease Drug Sales by Country
    • 10.1.2 Middle East and Africa Crohn's Disease Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Crohn's Disease Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Crohn's Disease Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description, Business Overview and Total Revenue
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Crohn's Disease Drug Products Offered
    • 11.1.5 AbbVie Recent Development
  • 11.2 Janssen Biotech
    • 11.2.1 Janssen Biotech Corporation Information
    • 11.2.2 Janssen Biotech Description, Business Overview and Total Revenue
    • 11.2.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Janssen Biotech Crohn's Disease Drug Products Offered
    • 11.2.5 Janssen Biotech Recent Development
  • 11.3 Takeda Pharmaceuticals
    • 11.3.1 Takeda Pharmaceuticals Corporation Information
    • 11.3.2 Takeda Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.3.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Takeda Pharmaceuticals Crohn's Disease Drug Products Offered
    • 11.3.5 Takeda Pharmaceuticals Recent Development
  • 11.4 UCB
    • 11.4.1 UCB Corporation Information
    • 11.4.2 UCB Description, Business Overview and Total Revenue
    • 11.4.3 UCB Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 UCB Crohn's Disease Drug Products Offered
    • 11.4.5 UCB Recent Development
  • 11.5 Amgen
    • 11.5.1 Amgen Corporation Information
    • 11.5.2 Amgen Description, Business Overview and Total Revenue
    • 11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Amgen Crohn's Disease Drug Products Offered
    • 11.5.5 Amgen Recent Development
  • 11.6 Tillotts Pharma
    • 11.6.1 Tillotts Pharma Corporation Information
    • 11.6.2 Tillotts Pharma Description, Business Overview and Total Revenue
    • 11.6.3 Tillotts Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Tillotts Pharma Crohn's Disease Drug Products Offered
    • 11.6.5 Tillotts Pharma Recent Development
  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description, Business Overview and Total Revenue
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Crohn's Disease Drug Products Offered
    • 11.1.5 AbbVie Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Crohn's Disease Drug Market Estimates and Projections by Region
    • 12.1.1 Global Crohn's Disease Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Crohn's Disease Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Crohn's Disease Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Crohn's Disease Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Crohn's Disease Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Crohn's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Crohn's Disease Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Crohn's Disease Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Crohn's Disease Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Crohn's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Crohn's Disease Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Crohn's Disease Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Crohn's Disease Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Crohn's Disease Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Crohn's Disease Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Crohn's Disease Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Crohn's Disease Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Crohn's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Crohn's Disease Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Crohn's Disease Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Crohn's Disease Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Crohn's Disease Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Crohn's Disease Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Crohn's Disease Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Crohn's Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crohn's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Crohn's Disease Drug market is segmented into
    Aminosalicylates
    Corticosteroids
    Immunomodulators
    Antibiotics

    Segment by Application, the Crohn's Disease Drug market is segmented into
    Achieving Remission (The Absence Of Symptoms)
    Maintaining Remission (Prevention Of Flare-Ups)
    Pediatric Crohn'S Disease

    Regional and Country-level Analysis
    The Crohn's Disease Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Crohn's Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Crohn's Disease Drug Market Share Analysis
    Crohn's Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Crohn's Disease Drug business, the date to enter into the Crohn's Disease Drug market, Crohn's Disease Drug product introduction, recent developments, etc.
    The major vendors covered:
    AbbVie
    Janssen Biotech
    Takeda Pharmaceuticals
    UCB
    Amgen
    Tillotts Pharma
    ...

    Buy now